Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 3/20 | 0.56 |
| ▸ | NOS1 | P29475 | 3/20 | 0.56 |
| ▸ | NOS2 | P35228 | 3/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.44 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL770417 | 1.00 | NOS3 (0.56) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| SCHEMBL9980878 | 1.00 | NOS3 (0.56) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| SCHEMBL770416 | 1.00 | NOS3 (0.56) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| Hydrochloric Acid SCHEMBL7592766 | 0.98 | NOS1 (0.55) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| Hydrochloric Acid SCHEMBL19209653 | 0.98 | NOS1 (0.55) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| Hydrogen Sulfide SCHEMBL22463012 | 0.98 | NOS3 (0.55) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| Hydrogen Sulfide SCHEMBL27825542 | 0.98 | NOS3 (0.55) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| SCHEMBL3868558 | 0.94 | NOS3 (0.51) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| Serine SCHEMBL3868560 | 0.92 | NOS3 (0.50) | NOS3NOS1NOS2SLC7A5SLC1A5 | |
| Serine SCHEMBL3868555 | 0.92 | NOS3 (0.50) | NOS3NOS1NOS2SLC7A5SLC1A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122081366-A | 5-Aminolevulinic acid production strain and construction method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122036541-A | Amino acid-based ionizable lipid compound, and preparation method and application thereof | 中国科学院广州生物医药与健康研究院 | 2026-05-15 | — | — | CN | claimed |
| WO-2026099434-A2 | EAMA TRANSPORTER MUTANTS AND USES THEREOF | CYSBIO APS (DK) | 2026-05-15 | — | — | WO | claimed |
| US-20260060962-A1 | METHODS AND AGENTS THAT STIMULATE MITOCHONDRIAL TURNOVER FOR TREATING DISEASE | CAPACITY BIO INC (US) | 2026-03-05 | — | — | US | claimed |
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | WASHINGTON UNIVERSITY | 2025-05-29 | — | — | US | claimed |
| EP-4441237-B1 | PROCESS FOR PRODUCING TAURINE | WACKER CHEMIE AG (DE) | 2025-03-26 | — | — | EP | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| US-20250002952-A1 | METHOD FOR PREPARING L-CYSTEIC ACID | WACKER CHEMIE AG (DE) | 2025-01-02 | — | — | US | claimed |
| CN-119220571-A | Construction method and application of amino acid high-yield strain | 中国科学院天津工业生物技术研究所 | 2024-12-31 | — | — | CN | claimed |
| CN-1200764-A | Process for preparing O-acetylsering, L-cysteine and L-cystein-related products | CONSORTIUM ELEKTROCHEM IND (DE) | 1998-12-02 | — | — | CN | claimed |
| US-5800804-A | DEODORIZING COMPOSITION USING AMINO ACID DERIVATIVES | THE GILLETTE COMPANY (US) | 1998-09-01 | — | — | US | claimed |
| EP-0785768-A4 | — | — | 1997-07-30 | — | — | EP | claimed |
| EP-0785768-A1 | O-ACYL SERINES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1997-07-30 | — | — | EP | claimed |
| US-5431904-A | O-acyl serines as deodorants | THE GILLETTE COMPANY (US) | 1995-07-11 | — | — | US | claimed |
| WO-1995007069-A1 | O-ACYL SERINES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1995-03-16 | — | — | WO | claimed |
| EP-0301873-B1 | 2'-deoxy-5-fluorouridine derivatives | TAIHO PHARMACEUTICAL CO LTD (JP) | 1994-06-08 | — | — | EP | claimed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | claimed |
| US-4946951-A | ANTICARCINOGENIC AND-TUMOR AGENTS; VIRICIDES | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1990-08-07 | — | — | US | claimed |
| EP-0301873-A2 | 2'-deoxy-5-fluorouridine derivatives | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1989-02-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | TMPRSS2, PRSS1, PRSS2 | NOS3 4110/4885NOS1 3845/4885NOS2 3560/4885 |
| US-20260060962-A1 | METHODS AND AGENTS THAT STIMULATE MITOCHONDRIAL TURNOVER FOR TREATING DISEASE | MDH2, NLN, PINK1 | NOS3 3753/4885NOS1 3569/4885NOS2 3617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.